A rapid hepatitis C test is now available.
The World Health Organization (WHO) on Monday announced it has prequalified its first hepatitis C virus (HCV) rapid diagnostic test, which will help diagnose HCV in low- and middle-income countries and potentially improve access to treatment.
The prequalification of South Korea-based Standard Diagnostics’ point-of-care diagnostic, called SD BIOLINE HCV, comes as an increasing number of people in low- and middle-income countries are now gaining access to hepatitis C cures from Gilead, AbbVie and Janssen, among others.
Since the introduction of these new medicines in the last two years (hepatitis C is a disease that kills almost 700,000 annually), more than one million people have been treated in low- and middle-income countries including Argentina, Brazil, Egypt, Georgia, Indonesia, Morocco, Nigeria, Pakistan, Philippines, Romania, Rwanda, Thailand and Ukraine.
Read full article: WHO Prequalifies First Hepatitis C Diagnostic | RAPS
|Read Full Article: WHO Prequalifies First Hepatitis C Diagnostic | RAPS|